Silent abortion and Vaginal Microbiome – Therapy Pathway

Показати скорочений опис матеріалу

dc.contributor.author Artyomenko, V. en
dc.contributor.author Lahoda, D. en
dc.contributor.author Zhelezov, D. en
dc.contributor.author Kozhuhar, G. en
dc.contributor.author Derishov, S. en
dc.date.accessioned 2025-01-24T07:14:02Z
dc.date.available 2025-01-24T07:14:02Z
dc.date.issued 2024
dc.identifier.citation Silent abortion and Vaginal Microbiome – Therapy Pathway. Clinical case / Artyomenko V. et al Вагінальни дисбіози : наук. конф., м. Ужгород, 16-17 травня 2024. en
dc.identifier.uri https://repo.odmu.edu.ua:443/xmlui/handle/123456789/16719
dc.description.abstract The problem of spontaneous pregnancy termination or miscarriage occupies one of the leading places in obstetric practice. According to statistics, miscarriages occur in 15% of clinically confirmed pregnancies in the general population. New evidence indicates that the reproductive tract microbiome plays an important role in immune responses, both local and general, in the pregnant woman body. During pregnancy, the increased estrogen level contributes to glycogen accumulation in the vaginal epithelium, which, accordingly, supports Lactobacillus spp. dominance and stability during pregnancy. Today, although we have a number of recent data that indicate the role of the vaginal and cervical canal microbiome as a predictor of miscarriage. en
dc.language.iso en en
dc.subject spontaneous pregnancy termination en
dc.title Silent abortion and Vaginal Microbiome – Therapy Pathway en
dc.type Article en


Долучені файли

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу